| Financial Year |
March 31 2023 |
| Monetary Funds |
698,377,280.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
652,156,913.92 |
| Accounts Receivable |
1,214,334,878.83 |
| Advances to Suppliers |
146,954,025.27 |
| Other Receivables |
9,762,768.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,686,955,777.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,883,028.02 |
| Total Current Assets |
4,577,240,599.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
164,481,136.09 |
| Investment Properties |
3,937,193.71 |
| Fixed Assetes |
1,449,276,484.19 |
| Under-construction Projects |
147,274,566.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
230,170,753.29 |
| R&D expenses |
24,124,300.93 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,962,023.73 |
| Deferred Income Tax Assets |
70,818,395.64 |
| Other Non-Current Assets |
68,308,140.42 |
| Sub-Total of Non-Current Assets |
2,309,924,393.46 |
| Total Assets |
6,887,164,993.16 |
| Short-Term Loans |
1,219,267,173.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
291,656,912.34 |
| Accounts Payable |
535,896,173.50 |
| Accounts Received In Advance |
1,629,367.68 |
| Employee Compensation Payable |
105,747,765.89 |
| Taxes Payable |
23,974,019.84 |
| Interest Payable |
-- |
| Dividend Payable |
5,851,800.00 |
| Other payables |
24,670,053.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
195,794,501.92 |
| Other Current Liabilities |
301,579,137.10 |
| Sub-Total of Current Liabilities |
2,844,463,303.23 |
| Long-term Loans |
519,454,683.41 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,400,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,558,120.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
792,512,323.60 |
| Total Liabilities |
3,636,975,626.83 |
| Paid-In Capital(Or Share Stock) |
488,214,274.00 |
| Capital Surplus |
1,924,143,830.74 |
| Surplus Reserve |
64,344,466.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
323,543,103.96 |
| Minority Stockholder's Interest |
412,878,576.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,837,310,789.36 |
| Owner's Equity（Stockholder's Equity） |
3,250,189,366.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,887,164,993.16 |
